Mari-Anne Vals1,2,3, Maria Yakoreva1,2, Tiina Kahre1,2, Pille Mee4, Kai Muru1,2, Kairit Joost1, Rita Teek1,2, Lukas Soellner5, Thomas Eggermann5, Katrin Õunap1,2. 1. 1 Department of Genetics, United Laboratories, Tartu University Hospital , Tartu, Estonia . 2. 2 Department of Pediatrics, University of Tartu , Tartu, Estonia . 3. 3 Children's Clinic, Tartu University Hospital , Tartu, Estonia . 4. 4 United Laboratories, Tartu University Hospital , Tartu, Estonia . 5. 5 Institute of Human Genetics , RWTH Aachen, Aachen, Germany .
Abstract
AIMS: To study the frequency of methylation abnormalities among Estonian patients selected according to published clinical diagnostic scoring systems for Silver-Russell syndrome (SRS) and Beckwith-Wiedemann syndrome (BWS). MATERIALS AND METHODS: Forty-eight patients with clinical suspicion of SRS (n = 20) or BWS (n = 28) were included in the study group, to whom methylation-specific multiplex ligation-dependant probe amplification analysis of 11p15 region was made. In addition, to patients with minimal diagnostic score for either SRS or BWS, multilocus methylation-specific single nucleotide primer extension assay was performed. RESULTS: Five (38%) SRS patients with positive clinical scoring had abnormal methylation pattern at chromosome 11p15, whereas in the BWS group, only one patient was diagnosed with imprinting control region 2 (ICR2) hypomethylation (8%). An unexpected hypomethylation of the PLAGL1 (6q24) and IGF2R (6q25) genes in the patient with the highest BWS scoring was found. CONCLUSIONS: Compared to BWS, diagnostic criteria used for selecting SRS patients gave us a similar detection rate of 11p15 imprinting disorders as seen in other studies. A more careful selection of patients with possible BWS should be considered to improve the detection of molecularly confirmed cases. Genome-wide multilocus methylation tests could be used in routine clinical practice as it increases the detection rates of imprinting disorders.
AIMS: To study the frequency of methylation abnormalities among Estonian patients selected according to published clinical diagnostic scoring systems for Silver-Russell syndrome (SRS) and Beckwith-Wiedemann syndrome (BWS). MATERIALS AND METHODS: Forty-eight patients with clinical suspicion of SRS (n = 20) or BWS (n = 28) were included in the study group, to whom methylation-specific multiplex ligation-dependant probe amplification analysis of 11p15 region was made. In addition, to patients with minimal diagnostic score for either SRS or BWS, multilocus methylation-specific single nucleotide primer extension assay was performed. RESULTS: Five (38%) SRSpatients with positive clinical scoring had abnormal methylation pattern at chromosome 11p15, whereas in the BWS group, only one patient was diagnosed with imprinting control region 2 (ICR2) hypomethylation (8%). An unexpected hypomethylation of the PLAGL1 (6q24) and IGF2R (6q25) genes in the patient with the highest BWS scoring was found. CONCLUSIONS: Compared to BWS, diagnostic criteria used for selecting SRSpatients gave us a similar detection rate of 11p15 imprinting disorders as seen in other studies. A more careful selection of patients with possible BWS should be considered to improve the detection of molecularly confirmed cases. Genome-wide multilocus methylation tests could be used in routine clinical practice as it increases the detection rates of imprinting disorders.
Authors: V Gaston; Y Le Bouc; V Soupre; L Burglen; J Donadieu; H Oro; G Audry; M P Vazquez; C Gicquel Journal: Eur J Hum Genet Date: 2001-06 Impact factor: 4.246
Authors: Deborah J G Mackay; Jonathan L A Callaway; Sophie M Marks; Helen E White; Carlo L Acerini; Susanne E Boonen; Pinar Dayanikli; Helen V Firth; Judith A Goodship; Andreas P Haemers; Johanne M D Hahnemann; Olga Kordonouri; Ahmed F Masoud; Elsebet Oestergaard; John Storr; Sian Ellard; Andrew T Hattersley; David O Robinson; I Karen Temple Journal: Nat Genet Date: 2008-07-11 Impact factor: 38.330
Authors: Jet Bliek; Gaetano Verde; Jonathan Callaway; Saskia M Maas; Agostina De Crescenzo; Angela Sparago; Flavia Cerrato; Silvia Russo; Serena Ferraiuolo; Maria Michela Rinaldi; Rita Fischetto; Faustina Lalatta; Lucio Giordano; Paola Ferrari; Maria Vittoria Cubellis; Lidia Larizza; I Karen Temple; Marcel M A M Mannens; Deborah J G Mackay; Andrea Riccio Journal: Eur J Hum Genet Date: 2008-12-17 Impact factor: 4.246
Authors: D Bartholdi; M Krajewska-Walasek; K Ounap; H Gaspar; K H Chrzanowska; H Ilyana; H Kayserili; I W Lurie; A Schinzel; A Baumer Journal: J Med Genet Date: 2008-12-09 Impact factor: 6.318